Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 12Non-Muscle Invasive Bladder Neoplasms 9Carcinoma, Transitional Cell 7Stomach Neoplasms 4Anus Neoplasms 4Pancreatic Neoplasms 3Carcinoma, Hepatocellular 3Peritoneal Neoplasms 2Liver Neoplasms 2Colorectal Neoplasms 2Appendiceal Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pseudomyxoma Peritonei 1Neoplasms by Site 1Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Mycobacterium Infections 1Gastrointestinal Neoplasms 1Dermatitis 1Carcinoma in Situ 1Carcinoma 1Anal Canal Carcinoma 1Adenocarcinoma 1

Interventions

Mitomycin 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pseudomyxoma Peritonei × Mitomycin × Clear all
NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Albert Einstein College of Medicine

Phase 2 Completed
51 enrolled 12 charts
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡